Catalyst Wire Dossier Catalyst Wire Dossier

ALKS 37

RDC-1036 · Alkermes, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALKS 37, covering 2012-06-13 to 2012-08-07. Get the full timeline:

Most recent: Clinical Trial Update: ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) [Phase 2]

See pricing